Ultrasound contrast agents: Examples of blood pool agents

Acta Radiologica, Supplement

Volumn 38, Issue 412, 1997, Pages 101-112

  Correas, J M ^a   Helenon O ^a   Pourcelot, L ^b   Moreau, J F ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CHU BRETONNEAU   (France)

Author keywords

Contrast agents, color Doppler imaging; Tumors, ultrasound

Indexed keywords

CONTRAST MEDIUM;

CHEMISTRY; CLASSIFICATION; ECHOGRAPHY; HUMAN; METHODOLOGY; REVIEW; TISSUE DISTRIBUTION;

CONTRAST MEDIA; HUMANS; TISSUE DISTRIBUTION; ULTRASONOGRAPHY;

EID: 0000853490     PISSN: 03655954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. ANDRÉ M. P., STEINBACH G. & MATTREY R. F.: Enhancement of the echogenicity of flowing blood by the contrast agent perflubron. Invest. Radiol. 28 (1993), 502.
2. BARNHART J. L., LEVENE H., VILLAPANDO B. S. et al.: Airfilled albumin microspheres for echocardiography contrast enhancement. Invest. Radiol. 25 (1990), 162.
3. BEHAN M., O'CONNELL D., MATTREY R. F. & CARNEY D. N.: Perfluorooctylbromide as a contrast agent for CT and sonography. Preliminary clinical results. AJR 160 (1993), 399.
4. BEPPU S., MATSUDA H., SHISHIDO T. & MIYATAKE K.: Success of myocardial contrast echocardiography by peripheral venous injection method. Visualization of area at risk. Circulation 4 (1993), I-401.
5. BRUNETON J. N., FALEWEE M. N., FRANCOIS E. et al.: Liver, spleen, and vessels. Preliminary clinical results of CT with perfluorooctylbromide. Radiology 170 (1989), 179.
6. BURNS P. N., POWERS J. E. & FRITZSCH T.: Harmonic imaging. A new imaging and Doppler method for contrast enhanced ultrasound. Radiology Suppl. 185P (1992), p. 142.
7. CAMPANI R., BOZZINI A., CALLIADA F. et al.: Impiego di un mezzo di contraste per ecografia SHU 508A (Levovist) Schering nello studio delle metastasi epatiche con color-Doppler. Radiol. Med. Suppl. 187 (1994), p. 32.
8. CARROLL B. A., TURNER R. J., TICKNER E. G., BOYLE D. B. & YOUNG S. W.: Gelatin encapsulated nitrogen microbubbles as ultrasonic contrast agents. Invest. Radiol. 15 (1980), 260.
9. CORREAS J.-M., MOREAU J. F. & POURCELOT L.: Les produits de contraste injectables en échographie-Doppler. In: Echo-Doppler, p. 27. Edited by M. Claudon & N. Grenier. Société Française de Radiologie, Paris 1995.
10. DEICHERT U., SCHLIEF R., VAN DE SANDT M. & JUHNKE I.: Transvaginal hysterosalpingo-contrast-sonography (Hy-Co-Sy) compared with conventional tubal diagnostics. Hum. Reprod. 4 (1989), 418.
11. EPSTEIN P. S. & PLESSET M. S.: On the stability of gaz bubbles in liquid-gas solutions. J. Chem. Phys. 18 (1950), 1505.
12. FEIGENBAUM H., STONE J. M., LEE D. A., NASSER W. K. & CHANG S.: Identification of ultrasound echoes from the left ventricle by use of intracardiac injections of indocyanine green. Circulation 41 (1970), 615.
13. FEINSTEIN S. B., CHEIRIF J., TEN CATE F. J. et al.: Safety and efficacy of a new transpulmonary ultrasound agent. Initial multicenter clinical results. J. Am. Coll. Cardiol. 16 (1990), 316.
14. FEINSTEIN S. B., SHAH P. M., BING R. J. et al.: Microbubble dynamics visualized in the intact capillary circulation. J. Am. Coll. Cardiol. 4 (1984), 595.
15. FINK I. J., MILLER D. J. & SHAWKER T. H.: Lipid emulsions as contrast agents for hepatic sonography. An experimental study in rabbits. Ultrason. Imaging 7 (1985), 191.
16. FRITZSCH T., HAUFF P., HELDMANN D., LUDERS F., UHLENDORF V. & WEITSCHIES W.: Preliminary results with a new liver-specific ultrasound contrast agent. Ultrasound Med. Biol. Suppl. 20(1994), p. S137.
17. GOLDBERG B. B., HILPERT P., BURNS P. N. et al.: Hepatic tumors. Signal enhancement of Doppler US after intravenous injection of a contrast agent. Radiology 177 (1990), 713.
18. GRAMIAK R. & SHAH P. M.: Echocardiography of the aortic root. Invest. Radiol. 3 (1968), 356.
19. GRAMIAK R., SHAH P. M. & KRAMER D. H.: Ultrasound cardiography. Contrast study in anatomy and function. Radiology 92 (1969), 939.
20. HILPERT P. L., MATTREY R. F., MITTEN R. M. & PETERSON T.: I.v. injection of air-filled human albumin microspheres to enhance arterial Doppler signal. A preliminary study in rabbits. AJR 153 (1989), 613.
21. KELLER M. W., FEINSTEIN S. B., BRILLER R. A. & POWSNER S. M.: Automated production and analysis of echo contrast agents. J. Ultrasound Med. 5 (1986), 493.
22. KERBER R. E., KIOSCHOS J. M. & LAUER R. M.: Use of an ultrasonic contrast method in the diagnosis of valvular regurgitation and intracardiac shunts. Am. J. Cardiol. 34 (1974), 722.
23. KREMKAU F. W., GRAMIAK R., CARSTENSEN E. L., SHAH P. M. & KRAMER H.: Ultrasonic detection of cavitation at catheter tips. AJR 110 (1970), 177.
24. MATTREY R. F.: Perfluorooctylbromide. A new contrast agent for CT, sonography, and MR imaging. AJR 152 (1989), 247.
25. MATTREY R. F., SCHEIBLE F. W., GOSINK B. B., LEOPOLD G. R., LONG D. M. & HIGGINS C. B.: Perfluorooctylbromide. A liver/spleen-specific and tumor-imaging ultrasound contrast material. Radiology 145 (1982), 759.
26. MELTZER R. S., TICKNER E. G. & POPP R. L.: Why do the lungs clear ultrasonic contrast? Ultrasound Med. Biol. 6 (1980), 263.
27. NEPPIRAS E. A., NYBORG W. L., MILLER P. L. et al.: Nonlinear behavior and stability of trapped micron-sized cylindrical gas bubbles in an ultrasound field. Ultrasonics 21 (1983), 109.
28. NUMATA K., TANAKA K., MITSUI K. et al.: Flow characteristics of hepatic tumors at color Doppler sonography. Correlation with arteriographic findings. AJR 160 (1993), 512.
29. OPHIR J., MCWHIRT R. E. & MAKLAD N. F.: Aqueous solutions as potential ultrasonic contrast agents. Ultrason. Imaging 1 (1979), 265.
30. OPHIR J. & PARKER K. J.: Contrast agents in diagnostic ultrasound. Ultrasound Med. Biol. 15 (1989), 319.
31. PARKER K. J.: A particulate contrast agent with potential for ultrasound imaging of liver. Ultrasound Med. Biol. 13 (1987), 555.
32. PARKER K. J., BAGGS R. B., LERNER R. M., TUTHILL T. A. & VIOLANTE M. R.: Ultrasound contrast for hepatic tumors using IDE particles. Invest. Radiol. 25 (1990), 1135.
33. PORTER T.: Improved myoocardial echocardiographic contrast with second harmonic transient response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. First Eur. Symp. Ultrasound Contrast Imaging, Rotterdam 1996.
34. QUAY S. C.: Microbubble-based ultrasound contrast agents. The role of gas selection in microbubble persistence. J. Ultrasound Med. 13 (1994), S9.
35. QUAY S. C.: Ultrasound contrast agent development. Phase shift colloids. J. Ultrasound Med. 13 (1994), S9.
36. SAHN D. J. & VALDEZ-CRUZ L. M.: Ultrasonic contrast studies for the detection of cardiac shunts. J. Am. Coll. Cardiol. 3 (1984), 978.
37. SCHLIEF R. & DEICHERT U.: Hysterosalpingo-contrastsonography. Results of a clinical trial with a new ultrasound contrast medium in 120 patients. Radiology 178 (1991), 213.
38. SCHNEIDER M., BUSSAT P., BARRAU M.-B., ARDITI M., YAN F. & HYBL E.: Polymeric microballoons as ultrasound contrast agents. Physical and ultrasonic properties compared with sonicated albumin. Invest. Radiol. 27 (1992), 134.
39. SCHÜRMANN R. & SCHLIEF R.: Mezzi di contraste a base di saccarosio. Caratteristiche e potenzialit diagnostiche. Radiol. Med. Suppl. 87 (1994), p. 15.
40. SCHWARZ K. Q., BEZANTE G. P., BECHER H. et al.: Efficacia del mezzo di contrasto SHU 508 A (Levovist) nella valutazione di diversi distretti vascolari con il Doppler. Radiol. Med. Suppl. 87 (1994), p. 3.
41. SMITH M. D., KWAN O. I., REISER H. J. & DEMARIA A. N.: Superior intensity and reproducibility of SHU 454, a new right heart contrast agent. J. Am. Coll. Cardiol. 3 (1984), 992.
42. TANAKA S., KITAMURA T., NUMATA K. et al.: Color Doppler flow imaging of liver tumors. AJR 154 (1990), 509.
43. UNGER E. C., LUND P. J., SHEN D.-K., FRITZ T. A., YELLOWHAIR D. & NEW T. E.: Nitrogen-filled liposomes as a vascular US contrast agent. Preliminary evaluation. Radiology 185 (1992), 453.
44. ZISKIN M. C., BONAKDAPOUR A., WEINSTEIN D. P. & LYNCH P. R.: Contrast agents for diagnostic ultrasound. Invest. Radiol. 6 (1972), 500.